348 related articles for article (PubMed ID: 15477045)
1. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
[TBL] [Abstract][Full Text] [Related]
2. Aryloxoalcanoic compounds induce resistance to antibiotic therapy in urinary tract infection caused by Escherichia coli.
Balagué C; Stürtz N; Rey R; De Ruiz CS; Nader-Macías ME; Duffard R; De Duffard AM
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):337-46. PubMed ID: 17034416
[TBL] [Abstract][Full Text] [Related]
3. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
[TBL] [Abstract][Full Text] [Related]
4. Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney.
Rice JC; Peng T; Spence JS; Wang HQ; Goldblum RM; Corthésy B; Nowicki BJ
J Am Soc Nephrol; 2005 Dec; 16(12):3583-91. PubMed ID: 16236807
[TBL] [Abstract][Full Text] [Related]
5. Protection against experimental pyelonephritis by antibodies to pili.
Silverblatt FJ; Weinstein R; Rene P
Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
[TBL] [Abstract][Full Text] [Related]
6. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
Pecha B; Low D; O'Hanley P
J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
[TBL] [Abstract][Full Text] [Related]
7. [Modulation of P-fimbriation by ciprofloxacin in uropathogenic Escherichia coli].
Abalia I; Rodríguez E; Umaran A; Lacalle J; Sarasua A; Huarte M; Ramón Bilbao J
Enferm Infecc Microbiol Clin; 1997 May; 15(5):255-9. PubMed ID: 9376383
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis.
O'Hanley P; Lark D; Falkow S; Schoolnik G
J Clin Invest; 1985 Feb; 75(2):347-60. PubMed ID: 2857730
[TBL] [Abstract][Full Text] [Related]
9. Effects of subinhibitory concentrations of antibiotics and antibodies on the adherence of Escherichia coli to human uroepithelial cells in vitro.
Stenqvist K; Sandberg T; Ahlstedt S; Korhonen TK; Svanborg-Edén C
Scand J Infect Dis Suppl; 1982; 33():104-7. PubMed ID: 6127798
[No Abstract] [Full Text] [Related]
10. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae.
Bidhendi SM; Sattari M; Pourbakhsh SA; Mobarez A; Vandyousefi J; Khaki P; Heidari MH; Kazemnejad A
Biologicals; 2007 Apr; 35(2):99-105. PubMed ID: 16879977
[TBL] [Abstract][Full Text] [Related]
11. Experimental pyelonephritis in mice following ascending infection with C. coli. Acute phase.
Tanaka N; Une T; Ogawa H
Acta Pathol Jpn; 1981 Mar; 31(2):179-87. PubMed ID: 7020331
[TBL] [Abstract][Full Text] [Related]
12. Synthetic peptides protect against infection in a model of experimental pyelonephritis in mice.
Schmidt MA; O'Hanley P; Schoolnik GK
Ann Sclavo Collana Monogr; 1986; 3(1-2):389-98. PubMed ID: 3322342
[No Abstract] [Full Text] [Related]
13. Suckling mouse model of urinary tract infections caused by Escherichia coli.
Kétyi I
Acta Microbiol Acad Sci Hung; 1981; 28(4):393-9. PubMed ID: 6119007
[TBL] [Abstract][Full Text] [Related]
14. Do type 1 fimbriae promote inflammation in the human urinary tract?
Bergsten G; Wullt B; Schembri MA; Leijonhufvud I; Svanborg C
Cell Microbiol; 2007 Jul; 9(7):1766-81. PubMed ID: 17359236
[TBL] [Abstract][Full Text] [Related]
15. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.
Layton GT; Smithyman AM
Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434
[TBL] [Abstract][Full Text] [Related]
16. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
[TBL] [Abstract][Full Text] [Related]
17. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
Hagberg L; Engberg I; Freter R; Lam J; Olling S; Svanborg Edén C
Infect Immun; 1983 Apr; 40(1):273-83. PubMed ID: 6339403
[TBL] [Abstract][Full Text] [Related]
18. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.
Nishikawa H; Yasuda M; Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Ujihara T; Shimizu Y; Shuin T; Matsuzaki S
Arch Virol; 2008; 153(3):507-15. PubMed ID: 18188500
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
[TBL] [Abstract][Full Text] [Related]
20. Effect of subminimal inhibitory concentrations of pefloxacin on the piliation and adherence of E. coli.
Desnottes JF; Le Roy D; Diallo N
Drugs Exp Clin Res; 1988; 14(10):629-34. PubMed ID: 2907737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
